Prognostic Utility of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiation Therapy for Cervical Cancer

dc.contributor.authorOnal, C.
dc.contributor.authorGuler, O. C.
dc.contributor.authorYildirim, B. Akkus
dc.contributor.orcID0000-0001-6908-3412en_US
dc.contributor.orcID0000-0001-6661-4185en_US
dc.contributor.researcherIDHOC-5611-2023en_US
dc.contributor.researcherIDAAC-5654-2020en_US
dc.contributor.researcherIDV-5717-2017en_US
dc.date.accessioned2023-06-16T08:25:05Z
dc.date.available2023-06-16T08:25:05Z
dc.date.issued2016
dc.identifier.endpageS51en_US
dc.identifier.issn0360-3016en_US
dc.identifier.issue2en_US
dc.identifier.startpageS51en_US
dc.identifier.urihttp://hdl.handle.net/11727/9649
dc.identifier.volume96en_US
dc.identifier.wos000387655804449en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.ijrobp.2016.06.133en_US
dc.relation.journalINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlePrognostic Utility of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiation Therapy for Cervical Canceren_US
dc.typeConference Objecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: